Pipeline

INTERFERON ALPHA-2B (INHALATION)

AREA: COVID-19
PRODUCT: AntiCovir (AP-003)
INDICATION: Early stage COVID-19
STATUS: Randomized, double-blind, placebo controlled trial, powered for Phase 3 registration

DISCOVERY

PRE-CLINICAL

 

IND

 

PHASE 1

 

PHASE 2

 

PHASE 3

INTERFERON ALPHA-2B (TOPICAL BIPHASIX CREAM)

AREA: HPV GENITAL (Female)
PRODUCT: AP-001
INDICATION:
HPV Cervical High grade intraepithelial lesion (HSIL)
STATUS:
Randomized, double-blind Phase 2b to start Q1 2021

DISCOVERY

PRE-CLINICAL

 

IND

 

PHASE 1

 

PHASE 2

 

PHASE 3

GALLIUM BASED SMALL MOLECULE NCE (ORAL)

AREA: Solid Tumors with Bone Metastases or at Risk of Bone Metastases
PRODUCT: AP-002
INDICATION: Solid tumors (with focus on breast, lung and prostate cancers)
STATUS: Phase 1-2 [NCT04143789]; Ongoing

DISCOVERY

PRE-CLINICAL

 

IND

 

PHASE 1

 

PHASE 2

 

PHASE 3